[Hormonal and genotoxic aspects of BRCA1-associated carcinogenesis].
Bershteĭn
L M
LM
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001141:Aromatase / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism* / Q000517:prevention & control; D004249:DNA Damage; D005260:Female; D019398:Genes, BRCA1; D006801:Humans; D009152:Mutagenicity Tests; D009154:Mutation; D009376:Neoplasms, Hormone-Dependent / Q000235:genetics* / Q000378:metabolism; D018384:Oxidative Stress / Q000235:genetics; D011372:Progestins / Q000378:metabolism; D011944:Receptors, Androgen / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism
D018931:Antineoplastic Agents, Hormonal; D011372:Progestins; D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D001141:Aromatase